Thomas Stevens, CFA" »

Prelude Therapeutics shares owned by Thomas Stevens, CFA"

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Thomas Stevens, CFA" from 13F filings

Historical chart of Thomas Stevens, CFA" investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Thomas Stevens, CFA" consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Thomas Stevens, CFA"

Quarter filed Position value Share count Share price at filing
2026-06-30 $34k 6.4k 5.33

More positions owned by Thomas Stevens, CFA"

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Eli Lilly & Co Common Stock (LLY)
Meta Platforms Common Stock (META)
Howmet Aerospace Common Stock (HWM)
Micron Technology Common Stock (MU)
GE Vernova Common Stock (GEV)
Lam Research Corp Common Stock (LRCX)
Advanced Micro Devices Common Stock (AMD)
Amphenol Corp Common Stock (APH)

View all positions for Thomas Stevens, CFA"

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics